Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
88,623,711
-
Share change
-
-3,089,102
-
Total reported value
-
$10,894,004,580
-
Put/Call ratio
-
142%
-
Price per share
-
$122.95
-
Number of holders
-
337
-
Value change
-
-$352,121,911
-
Number of buys
-
178
-
Number of sells
-
129
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2018
As of 30 Sep 2018 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 337 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 88,623,711 shares of stock of the company.
Largest 10 holders included FMR LLC, Vanguard Group Inc, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, Invesco Ltd., FRANKLIN RESOURCES INC, and Artisan Partners Limited Partnership.
This table shows 339 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.